US FDA Deems Sun Pharma’s Halol Plant Not Compliant with Manufacturing Rules
Sept 9 (Reuters) – Indian drugmaker Sun Pharmaceutical Industries said on Tuesday that the U.S. Food and Drug Administration (FDA) had determined its Halol plant, located in the western state of Gujarat, was not compliant with the regulator’s […]
India Looking Beyond US for Pharma Exports Amid Tariff Tensions
NEW DELHI, Sept 4 – India is seeking to boost drug exports to semi-regulated markets in Africa, Latin America, and Southeast Asia to reduce its dependence on the U.S., where tariff […]